Combination benefit of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) and dexamethasone or indomethacin in adjuvant arthritic rats

1999 ◽  
Vol 48 (8) ◽  
pp. 453-460 ◽  
Author(s):  
A. M. Bendele ◽  
J. McComb ◽  
T. Gould ◽  
J. Frazier ◽  
E. S. Chlipala ◽  
...  
Keyword(s):  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Receptor ◽  
Receptor Type ◽  
Type I ◽  
Necrosis Factor

Neopterin and soluble tumor necrosis factor receptor type I in alcohol-induced cirrhosis

Hepatology ◽  
1995 ◽  
Vol 21 (4) ◽  
pp. 976-978 ◽  
Author(s):  
Antonio Diez-Ruiz ◽  
Gernot P. Tilz ◽  
Francisco Gutierrez-Gea ◽  
Blas Gil-Extremera ◽  
Christian Murr ◽  
...  
Keyword(s):  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Receptor ◽  
Receptor Type ◽  
Type I ◽  
Necrosis Factor

Clinical Significance of Serum CA-125 and Soluble Tumor Necrosis Factor Receptor Type I in Cervical Adenocarcinoma Patients

2010 ◽  
Vol 20 (4) ◽  
pp. 588-592 ◽  
Author(s):  
Beata Kotowicz ◽  
Janina Kaminska ◽  
Malgorzata Fuksiewicz ◽  
Maria Kowalska ◽  
Joanna Jonska-Gmyrek ◽  
...  
Keyword(s):  
Tumor Necrosis Factor ◽  
Clinical Significance ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Receptor ◽  
Cervical Adenocarcinoma ◽  
Receptor Type ◽  
Ca 125 ◽  
Type I ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document